---
category: news
title: "We Should Test AI the Way the FDA Tests Medicines"
excerpt: "To prevent this, we should submit new algorithms to randomized controlled trials, similar to those the FDA supervises when approving new drugs. This would enable us to infer whether an AI is making predictions on the basis of causation."
publishedDateTime: 2021-06-28T12:35:00Z
originalUrl: "https://hbr.org/2021/06/we-should-test-ai-the-way-the-fda-tests-medicines"
webUrl: "https://hbr.org/2021/06/we-should-test-ai-the-way-the-fda-tests-medicines"
ampWebUrl: "https://hbr.org/amp/2021/06/we-should-test-ai-the-way-the-fda-tests-medicines"
cdnAmpWebUrl: "https://hbr-org.cdn.ampproject.org/c/s/hbr.org/amp/2021/06/we-should-test-ai-the-way-the-fda-tests-medicines"
type: article
quality: 57
heat: 57
published: false

provider:
  name: Harvard Business Review
  domain: hbr.org

topics:
  - AI

images:
  - url: "https://hbr.org/resources/images/article_assets/2021/06/Jun21_28_1277171922.jpg"
    width: 1200
    height: 675
    isCached: true

secured: "hxwp5n7C1V2MhFk3sRXeXDdhYSZfahSyilf5cSmOBJT9T30eiZ2D9V8SNledFdV8meEzkRaSkHW14Rwr7f2mhLubNfUTBqe5O4bPUmqjASbSqh/n646Q1vygc38eTJZLRU2YUrF+X+EQzk8hq1OolN3QVFt+zl7M410LNJ4mlht/YsXwAQq1jwMZ4i3s6a/HJax86JyCvsOiIBjS+PSAMJhDcyx3hc2viBf59n0CBnTZGYucUiN8kzrhACGyXq0RzXsaEe82aaX69VgSnesoEDJFZl9uRETeKcumW3rCeJJ22LYYO70gElE6/WR6veSomC1ji73b02182Ytfo+gbFfD/QaXT80nutnHmmK6d+gs=;3EB0nL21ukGr3JNSIxDPLg=="
---

